Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis.
Gil YosipovitchMarjolein de Bruin-WellerApril W ArmstrongJashin J WuPedro Herranz PintoDiamant ThaҫiDimittri DelevryGaëlle Bégo-Le BagousseRaymond ZhangBrad ShumelAna Beatris RossiJingdong ChaoPublished in: Dermatology and therapy (2021)
ClinicalTrials.gov Identifier: NCT01949311. Supplementary material 1 (MP4 552250 kb).